BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3602952)

  • 21. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
    O'Mahony S; Anderson N; Nuki G; Ferguson A
    Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elisa studies in ankylosing spondylitis.
    Panayi GS
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):119-21. PubMed ID: 6652391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the gram-negative bacterial flora in patients with ankylosing spondylitis.
    Ferraz MB; Atra E; Trabulsi LR; Goldenberg J; Sato EI
    Braz J Med Biol Res; 1990; 23(1):29-36. PubMed ID: 2386846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis.
    Mäki-Ikola O; Nissilä M; Lehtinen K; Leirisalo-Repo M; Toivanen P; Granfors K
    Br J Rheumatol; 1995 May; 34(5):413-7. PubMed ID: 7788168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ankylosing spondylitis is caused by Klebsiella. Evidence from immunogenetic, microbiologic, and serologic studies.
    Ebringer A
    Rheum Dis Clin North Am; 1992 Feb; 18(1):105-21. PubMed ID: 1561397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.
    Vuento R; Eskola J; Leino R; Koskimies S; Viander M
    Ann Rheum Dis; 1984 Apr; 43(2):186-91. PubMed ID: 6370149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls.
    Baines M; Ebringer A; Avakian H; Samuel D; James DC
    Scand J Rheumatol; 1990; 19(5):341-9. PubMed ID: 1699267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of raised serum IgA in ankylosing spondylitis with IgA nephropathy.
    Chou CT; Lee CF; Shieh SD; Huang HW; Ho YS
    Taiwan Yi Xue Hui Za Zhi; 1984 Dec; 83(12):1232-7. PubMed ID: 6597853
    [No Abstract]   [Full Text] [Related]  

  • 30. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS; Geczy AF
    Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between Klebsiella infection and ankylosing spondylitis.
    Ebringer A
    Baillieres Clin Rheumatol; 1989 Aug; 3(2):321-38. PubMed ID: 2670258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis.
    Mäki-Ikola O; Lehtinen K; Toivanen P; Granfors K
    Br J Rheumatol; 1995 May; 34(5):418-20. PubMed ID: 7788169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.
    Nissilä M; Lahesmaa R; Leirisalo-Repo M; Lehtinen K; Toivanen P; Granfors K
    J Rheumatol; 1994 Nov; 21(11):2082-7. PubMed ID: 7869314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raised serum IgA to common cell envelope antigens supports enterobacterial inductive contribution to pathogenesis of secondary ankylosing spondylitis.
    van Bohemen CG; Weterings E; Nabbe AJ; Mulder CJ; Goei The HS; Zanen HC
    Immunol Lett; 1987 Apr; 14(4):303-6. PubMed ID: 3583323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relation between serum and salivary IgA and oral aerobic bacterial flora in patients with chronic bronchitis].
    Misirligil Z; Saygun N; Yavuz S; Atakurt Y
    Mikrobiyol Bul; 1985 Jan; 19(1):23-8. PubMed ID: 3872401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.
    Sanders KM; Hertzman A; Escobar MR; Littman BH
    Ann Rheum Dis; 1987 Apr; 46(4):273-6. PubMed ID: 3592781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
    J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of gut inflammation with increased serum IgA class Klebsiella antibody concentrations in patients with axial ankylosing spondylitis (AS): implication for different aetiopathogenetic mechanisms for axial and peripheral AS?
    Mäki-Ikola O; Leirisalo-Repo M; Turunen U; Granfors K
    Ann Rheum Dis; 1997 Mar; 56(3):180-3. PubMed ID: 9135221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
    Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlamydia trachomatis serology in ankylosing spondylitis.
    Csángó PA; Upsahl MT; Romberg O; Kornstad L; Sarov I
    Clin Rheumatol; 1987 Sep; 6(3):384-90. PubMed ID: 3327642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.